M. BERMÚDEZ1, G. E. MERCADO-CELIS2, and H. ARZATE1, 1

Slides:



Advertisements
Similar presentations
Early Embryonic Development Maternal effect gene products set the stage by controlling the expression of the first embryonic genes. 1. Transcription factors.
Advertisements

Chapter 19 Lecture Concepts of Genetics Tenth Edition Cancer and Regulation of the Cell Cycle.
Introduction to Oncology Dr. Saleh Unit 9 R.E.B, 4MedStudents.com 2003.
Activity DNA microarray flow chart and predictions Mrs. Stewart
Cancer Genetics Is Cancer a Genetic Disease? Cancer is not a classic genetic disease, instead, Genetic background (set-up) has a definite role in cancer.
Describe the structure of a nucleosome, the basic unit of DNA packaging in eukaryotic cells.
Gene regulation in cancer 11/14/07. Overview The hallmark of cancer is uncontrolled cell proliferation. Oncogenes code for proteins that help to regulate.
Cancer Biology. 2 Outline 1.How do cancer cells differ from normal cells? Tumor progression Molecular basis for cancer.
Lecture #8Date _________ n Chapter 19~ The Organization and Control of Eukaryotic Genomes.
Figure S1. ID#1 Lipid Metabolism, Small Molecule Biochemistry, Drug Metabolism.
Copyright (c) by W. H. Freeman and Company Chapter 24 Cancer.
Chapter 20 oncogene, anti-oncogene and growth factor The biochemistry and molecular biology department of CMU.
How Genes are Controlled Chapter 11. Human Cells…. All share the same genome What makes them different????
NOTES: CH 18 part 2 - The Molecular Biology of Cancer
3.1.3.A Understanding Cancer What is Cancer.
Understanding Cancer. What Is Cancer? Different Kinds of Cancer Lung Breast (women) Colon Bladder Prostate (men) Some common sarcomas: Fat Bone Muscle.
Identification of network motifs in lung disease Cecily Swinburne Mentor: Carol J. Bult Ph.D. Summer 2007.
Chapter 11 Objectives Section 1 Control of Gene Expression
Cancer. Regulation of Cell Division Two sets of genes control cell division. –Proto-oncogenes. Code for proteins that promote the cell cycle and prevent.
The Effect of BRCA1 on the Progesterone Receptor.
S factor  body weight during WM  body weight during ER Supplementary figure 1: S factor distribution in each diet. S.
Cell Cycle and Cancer.
Cancer When cell division goes wrong……. Growing out of control, cancer cells produce malignant tumors Cancer is a general term for many diseases in.
Eukaryotic Genomes 15 November, 2002 Text Chapter 19.
Gene Expression. Cell Differentiation Cell types are different because genes are expressed differently in them. Causes:  Changes in chromatin structure.
oncogene, anti-oncogene and growth factor
ROLE OF GENE EXPRESSION:  Activation of a gene that results in a protein  Cells DO NOT need to produce proteins for every code. GENOME:  Complete genetic.
CHAPTER 19 THE ORGANIZATION AND CONTROL OF EUKARYOTIC GENOMES Copyright © 2002 Pearson Education, Inc., publishing as Benjamin Cummings Section D: The.
Eukaryotic Gene Control. Gene Organization: Chromatin: Complex of DNA and Proteins Structure base on DNA packing.
AH Biology: Unit 1 Control of the Cell Cycle. The cell cycle: summary G1G1 G2G2 S Interphase M Cytokinesis Mitosis.
Regulating The Cell Cycle. Warm Up – The Cell Cycle The cell spends 80% of the time in _______________ and 20% of the time in ________________ What are.
Supplemental Figure 2. IPA Gene Network Analysis. The top gene networks for DEGS more highly expressed (Panels A- B) and less highly expressed (Panels.
Eukaryotic Genomes 11 November, 2005 Text Chapter 19.
Types of Genes Associated with Cancer
Relationship Between STAT3 Inhibition and the Presence of p53 on Cyclin D1 Gene Expression in Human Breast Cancer Cell Lines Introduction STAT3 and p53.
Cancer. Cancer is a disease of the cell cycle Caused by one or more of the following: Increase in growth signals Loss of inhibitory signals In addition,
1. What is the Central Dogma? 2. How does prokaryotic DNA compare to eukaryotic DNA? 3. How is DNA organized in eukaryotic cells?
Tumor-suppressor genes Tumor-suppressor genes, function like brakes, keep cell numbers down, either by inhibiting progress through.
The Problem of Cancer. What are cancer cells ? Cancerous growth involves unrestrained proliferation (malignancy) and spread (metastasis). Caused by: mutations.
REGULATION OF GENE EXPRESSION
GENETIC BIOMARKERS.
MicroRNA-34a: a key regulator in the hallmarks of renal cell carcinoma
Nucleus:  is a membrane-enclosed organelle found in eukaryotic cells. It contains most of the cell's genetic material, organized as multiple long linear DNA.
Gene Expression.
Cancer, reproductive system diseases, lipid metabolism 48 22
The Genetic Basis of Cancer
Figure 3. Effects of SMFs on calcium content and osteoblastic or cementoblastic gene expression in a cell line of human PDLCs and cementoblasts. (A, B)
Regulation of the Cell Cycle & Cancer
Topic 7: The Organization and Control of Eukaryotic Genomes
Andrea L Kasinski, Frank J Slack  Molecular Therapy - Nucleic Acids 
M.B.Ch.B, MSC, DCH (UK), MRCPCH
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
Products > HepG2 Transfection Reagent (Hepatocellular Carcinoma)
Loyola Marymount University
Volume 143, Issue 2, Pages (November 2016)
by Gregory H. Underhill, David George, Eric G. Bremer, and Geoffrey S
Research Support Network (RAI)
Volume 22, Issue 1, Pages (January 2018)
Figure 1. BRCA1-associated R-Loop accumulation at a non-coding region upstream of ESR1 locus. (A) Alignment of DRIP-seq ... Figure 1. BRCA1-associated.
M.B.Ch.B, MSC, PhD, DCH (UK), MRCPCH
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
Shrimp miR-34 from Shrimp Stress Response to Virus Infection Suppresses Tumorigenesis of Breast Cancer  Yalei Cui, Xiaoyuan Yang, Xiaobo Zhang  Molecular.
Significant differences in translational efficiencies of DNA damage repair pathway genes between patient clusters. Significant differences in translational.
Loyola Marymount University
USP2a overexpression modifies the microRNA expression profile of prostate cells. USP2a overexpression modifies the microRNA expression profile of prostate.
Loyola Marymount University
Loyola Marymount University
Loyola Marymount University
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
Presentation transcript:

CEMP1-OVEREXPRESSION BY HUMAN GINGIVAL FIBROBLASTS: GENE EXPRESSION AND PROFILING ANALYSIS. M. BERMÚDEZ1, G.E. MERCADO-CELIS2, and H. ARZATE1, 1. Laboratorio de Biología de Periodontal y Tejidos Mineralizados, Facultad de Odontología, Universidad Nacional Autónoma de México, D.F., México. 2. Laboratorio de Oncogenómica, Instituto Nacional de Medicina Genómica, D.F., México. #965 RESULTS INTRODUCTION Cementum protein 1 (CEMP1) is encoded on chromosome 16p13.3 (2580036 .. 2581409, complementary chain) with a sequence of 1374 bp and a final product of 247 amino acids. CEMP1 is involved in cell adhesion, cell differentiation, regulates the mineralization processes during cementogenesis and selects progenitor cells from periodontal ligament. METHODS PREPROCESSING DATA AND DETECTION OF DIFFERENTIALY EXPRESSED (DE) TRANSCRIPTS FUNCTIONAL ANALYSIS TABLE1. INGENUITY SYSTEMS AND v6.7 NIH DAVID FUCTIONAL ANALYSIS Category p-value Molecules Cellular Development 4.4E-05-4.71E-02 PMEL,ABCB1,CLU,HBEGF,FGFR2,TPD52,HES1 (includes EG:15205),MET,STAT4,BNIP3,F11R,CDH1,CDH2,B4GALNT1,TFAP2A,HOXA5,NEO1,EPCAM,FKBP5,CXADR,CHD7,ELOVL7,HMGB2,NCAM1 Cellular Growth and Proliferation IL1RL1,POLA1,CLU,GPC4,HES1,HOXA9,BNIP3,PLCE1,TFAP2A,MCAM,HOXA5,NEO1,MYBL2,SERPINA1,FKBP5,ELOVL7,DTL,PMEL,ABCB1,PDZK1,FGFR2,HBEGF,BAMBI,TPD52,CDK1,MET,F11R,MAD2L1,ANKRD1,CDH1,CDH2,HABP2,TES,CKS1B,SPINT2,EPCAM,AK4,VAMP8,CXADR,HMGB2 Cell Death 7.82E-05-4.71E-02 REPS2,TRIM24,CLU,HES1,RBP1,BNIP3,TFAP2A,MCAM,KRT18,HOXA5,EGLN3,MYBL2,FKBP5,S100A1,DEPTOR,ABCB1,PDZK1,DAPK1,TOPBP1,FGFR2,HBEGF,MALT1,TPD52,CDK1,MET,MAD2L1,CDH1,CDH2,ANKRD1,DSG2,NCAM1 Cell Cycle 1.16E-04-3.94E-02 ABCB1,H19,TOPBP1,KRT7,POLA1,CLU,FGFR2,HBEGF,HES1,PDK3,CDK1,MET,MAD2L1,CDH1,CKS1B,MYBL2,CHRDL1,DTL Lipid Metabolism 1.9E-04-4.71E-02 LIPH,ABCB1,PIK3C2B,SLC27A2,EEF1A2,CLU,SLCO2A1,RBP1,B4GALNT1,PLCE1,ELOVL2,NEO1,SERPINA1,AGPAT9,FKBP5,PTGR2,ELOVL7 Cell Morphology 3.79E-04-4.71E-02 S100A1,MET,BNIP3,F11R,MAD2L1,CDH1,KRT18,HBEGF,CXADR,HOXD10,NCAM1 Cell-To-Cell Signaling and Interaction 3.79E-04-3.94E-02 MET,MAD2L1,CDH2,CDH1,MCAM,NEO1,HBEGF,EPCAM,DHFR,DSG2,CXADR,NCAM1 Cellular Compromise 3.79E-04-1.6E-02 MAD2L1,ABCB1,CDH1,CDH2,KRT18,MCAM,CLU,HBEGF Cellular Movement PIK3C2B,CLU,FGFR2,HBEGF,CDK1,HOXD10,MET,F11R,CDH2,CDH1,TFAP2A,MCAM,EPCAM,NEO1,SERPINA1,CXADR,HMGB2 DNA Replication, Recombination, and Repair 3.34E-03-4.71E-02 MAD2L1,BNIP3,ABCB1,IQGAP2,DAPK1,TOPBP1,KRT7,POLA1,CLU,CDK1 Carbohydrate Metabolism 3.35E-03-4.71E-02 PIK3C2B,ABCB1,LIPH,B4GALNT1,PLCE1,EEF1A2,GCNT2,NEO1,HBEGF,ALDOC Cellular Assembly and Organization PMEL,DAPK1,CLU,HBEGF,BNIP3,CDH1,KRT18,MCAM,TINAGL1,SNX10,SIK1,VAMP8,CXADR,HOOK1,SEMA7A,NCAM1 Amino Acid Metabolism 8.01E-03-8.01E-03 SLC17A7,DHFR Cell Signaling 8.01E-03-2.39E-02 MET,SLC24A2,IQGAP2,HBEGF,CDK1 Cellular Response to Therapeutics MET Drug Metabolism 8.01E-03-3.17E-02 ABCB1,SLCO2A1,DHFR,FKBP5,ELOVL7 Free Radical Scavenging CLU Gene Expression TFAP2A,CDK1 A. A. FILTER LogFch >2 or <-2 P-adjusted < 0.001 FIGURE 2. A) Data preprocessing included RMA background correction and Quantile Normalization using The Comprehensive R Archive Network and Partek Genomic Suite. B) Detection of differentially expressed trasnscripts results in 1025 genes that were obtained using a filter of logFCh of > 2 or <-2 and adjusted P<0.001 B. 1025 differentially expressed genes: 806 subexpressed 219 overexpressed B. FIGURE 3. A) For the functional analysis we used NIH DAVID (v6.7) and IPA; 39 “functional clusters” were identified, and the most relevant included cellular development, cellular growth and proliferation (most of this genes overexpressed), cell death (most of this genes subexpressed), and cell cycle genes. B) Heat map of functions. More genes are involved in function activation as the color gets closer to orange; more genes are involved in function suppression as the color gets closer to blue. TABLE 1. INGENUITY SYSTEMS AND v6.7 NIH DAVID FUCTIONAL ANALYSIS. Genes involved in Functional clusters. The most relevant are genes that regulate growth, some of them involved in tumorigenesis and apoptosis regulators and genes that stimulate cell proliferation (HOXA5, CDH1, CDH2, HBEGF, FGFR2, HMGB2 and MET). FIGURE 6. We performed microarrays (Human Gene 1.0 ST, Affymetrix) to identify differentially expressed transcripts between human gingival fibroblasts (HGF) and those that overexpress CEMP1 (HGF/CEMP1). Data were analyzed using Partek software (v6.3) and The Comprehensive R Archive Network(R-2.15.1). To validate the results we used Taqman Gene expression assays for real time PCR (Applied Biosystems.) VALIDATION A. B. Because of the expression of this genes we though CEMP1 could act as a protooncogene in case when its regulation fails. For this reason we sought expression of CEMP1 in 12 cancer cell lines (rabdomiosarcoma:RH28, RD, SMS; Ewing’s sarcoma: A673; breast cancer: T47D, MCF7, MDAM, HS587T; prostate cancer: PC3, 22RV1; hepatocellular carcinoma: HEPG2; cervical ephitelial cancer: HELA) CONCLUSION. CEMP1’s overexpression increased the expression of genes that regulate growth and cell proliferation; decreased apoptosis related-genes and importantly this gene is expressed in cancer cell lines. These results suggest that CEMP1 could be a protooncogene candidate. BONE AND MUSCLE BREAST PROSTATE LIVER UTERUS CEMENTUM FIGURE 1. A) CEMP1 is localized in cementoblasts throughout the entire surface of the root, cell subpopulations of the periodontal ligament as well as cells located paravascularly to the blood vessels into the periodontal ligament. B) CEMP1 promotes octacalcium phosphate crystal nucleation and possesses high affinity for hydroxyapatite.  C and D) Transfection of CEMP1 into human gingival fibroblasts (HGF) induces mineralization and expression of bone and cementum-matrix transcripts. They also produced insoluble calcium nodules. OBJECTIVE To know the gene expression pattern induced by CEMP1 overexpression in “non osteogenic” cells such as human gingival fibroblasts (HGF). BIBLIOGRAPHY. FIGURE 4. A)Genes for validation are involved in cancer related processes B)To validate the results, cell cultures of HGF/EV and HGF/CEMP were performed; The Absolute quantification (AQ) of expression for each gene was determined using the median expression level of three technical replicates using TaqMan Gene Expression Assays (Applied Biosystems). ( * P<0.05). FIGURE 5. All cell lines expressed CEMP1 as determined by theTaqman gene expression assay,. Some cell lines like MCF7 and 22RV1 expressed CEMP1 even more than the cementoblastic cell lines. Partially supported by grants from DGAPA-UNAM: IN216711; CONACyT: 130950 and INMEGEN